HEALTHCARE SERVICES · PE-BACKED TRANSACTIONS
Healthcare Services EBITDA multiples
The source reports a 8.5× average TTM adjusted EBITDA multiple through Q3 2025 for healthcare-services companies. See the five-year path before deciding whether the benchmark belongs in your analysis.
See the annual dataSource average
Reported average moved up
Rank #2 of 8 groups
9% of industry observations
YOUR EBITDA · INSTANT MARKET MATCH
Does the 8.5× healthcare services average fit your company's size?
Enter normalized EBITDA. The calculator keeps the Healthcare Services industry average separate from each reported company-size tier and removes any reference whose implied enterprise value falls outside its own source universe.
EBITDA → ENTERPRISE VALUE
Which reported market references fit your EBITDA?
Your EBITDA stays in this browser. We record only that the calculator was used—not the amount.
2021–2025 SOURCE HISTORY
The multiple moved. The universe stayed explicit.
The source's highest reported annual point in this period was 9.2× in 2023. Each bar is an average from a different period—not a valuation path for one company.
FROM BENCHMARK TO UNDERWRITING
The table answers “what did the group average?” It does not answer these three questions.
How diversified are payer and referral sources?
The aggregate source does not report this company-specific fact. A defensible valuation needs the answer before choosing or adjusting a multiple.
How dependent is the company on individual clinicians or owners?
The aggregate source does not report this company-specific fact. A defensible valuation needs the answer before choosing or adjusting a multiple.
What reimbursement and regulatory risks could change earnings?
The aggregate source does not report this company-specific fact. A defensible valuation needs the answer before choosing or adjusting a multiple.
FIT CHECK
Use this benchmark only inside its lane.
What is included
Private-equity-backed North American transactions with $10M–$250M of total enterprise value. Source period: Through Q3 2025.
What is not claimed
No individual transactions, median, quartiles, strategic-buyer premium, or universal private-company adjustment. This page does not reveal our protected transaction index.
SOURCE CONTRACT
The number stays attached to its source.
We transcribed the aggregate Healthcare Services row from GF Data's report. We did not infer missing ranges, blend in public-company trading multiples, or expose protected comparables.
YOUR NUMBERS
Normalize EBITDA. Then build the private valuation.
The market reference is public. Your company inputs, estimate, and contributed comparable access stay behind your account.
COMMON QUESTIONS
Healthcare Services EBITDA multiples
What EBITDA multiple did healthcare services companies receive in 2025?
Through Q3 2025, the source reports an average 8.5× TTM adjusted EBITDA multiple for healthcare-services companies. The universe is private-equity-backed North American transactions with $10 million to $250 million of total enterprise value.
Did the healthcare services EBITDA multiple change from 2024?
The reported average moved from 7.7× in 2024 to 8.5× through Q3 2025, a +0.8× change. The periods can contain different transactions, so this is a change in source averages, not same-company appreciation.
Can I use 8.5× to value my healthcare services company?
Use it as one market reference only if your company fits the source's size and buyer universe. Normalize EBITDA first, then test company-specific growth, margins, concentration, recurrence, management, capital needs, and deal terms. The benchmark is not an appraisal or an offer.
Does this benchmark include individual transactions?
No. This page presents only the source's aggregate annual averages and the all-years observation count for its broad industry group. No individual transaction or protected comparable is exposed.